Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Compounding is now limited to patient-specific prescriptions with a documented medical reason, such as an allergy to an inactive ingredient or a clinically justified dose that is not commercially available
A landmark phase 2 randomised controlled trial published in The Lancet in 2017 investigated exenatide in patients with moderate Parkinson's disease
However, women managing both conditions need more frequent monitoring and may need coordinated care between endocrinology and gynecology
They are typically the most cost-effective option per serving
US$ 22.61
US$ 20.94
US$ 21.58
US$ 29.65
